PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1672770
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1672770
Biomarker Research Services Market, By Service Type, By Disease Indication, By End User,By Geography
Global Biomarker Research Services Market is estimated to be valued at USD 10.98 Bn in 2025 and is expected to reach USD 310.66 Bn by 2032, growing at a compound annual growth rate (CAGR) of 61.2% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 10.98 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 61.20% | 2032 Value Projection: | USD 310.66 Bn |
The global biomarker research services market has been gaining significant traction over the recent past, owing to rising penetration of precision medicine and personalized healthcare. Biomarkers play a crucial role in drug development by identifying the risk of diseases and patients' response to therapies. They help streamline clinical trials and reduce costs associated with drug development. With increasing focus on biomarkers for early diagnosis of diseases and the development of targeted therapies, there has been huge demand for outsourced biomarker research services. Various biopharmaceutical companies are collaborating with research organizations to tap into their expertise and maximize efficiency of clinical research. This has boosted the growth of the global biomarker research services market.
Market Dynamics:
Global biomarker research services market is driven by rising demand for personalized medicine, increasing influence of precision medicine, and growth of companion diagnostics market. However, high costs associated with biomarker discovery and validation, and technical challenges in biomarker discovery are likely to restrain the market growth. Meanwhile, increasing focus on rare disease diagnosis presents high growth potential for players in this industry. Biomarkers play a critical role in drug development for rare diseases. Their use helps identify patients suitable for clinical trials and reduces costs. Growing adoption of biomarker profiling technologies, such as genomics and proteomics, offer lucrative opportunities in the near future.
Key Features of the Study:
This report provides in-depth analysis of the global biomarker research services market, and provides market size (US$ Billion) and the compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biomarker research services market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Johnson & Johnson Services, Inc., Qiagen, Epigenetics AG, General Electric, Merck KGaA, Illumina, Inc., PerkinElmer, Inc., Agilent Technologies, Becton, Dickinson and Company, and Novartis AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global biomarker research services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biomarker research services market
Market Segmentation
- By Service Type Insights (Revenue, USD Bn, 2019 - 2032)
- Biomarker Research Services
- Companion Diagnostics (CDx) Research Services
- By Disease Indication Insights (Revenue, USD Bn, 2019 - 2032)
- Cancer
- Cardiovascular Disorders
- Infectious Diseases
- Neurological Disorders
- Immunological Disorders
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2032)
- Hospitals
- Diagnostic Centers
- Specialty Centers
- Research Institutions
- Regional Insights (Revenue, USD Bn, 2019 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers AG
- Johnson & Johnson Services, Inc.
- Qiagen
- Epigenetics AG
- General Electric
- Merck KGaA
- Illumina, Inc.
- PerkinElmer, Inc.
- Agilent Technologies
- Becton, Dickinson and Company
- Novartis AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Biomarker Research Services Market, By Service Type
- Global Biomarker Research Services Market, By Disease Indication
- Global Biomarker Research Services Market, By End User
- Global Biomarker Research Services Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Biomarker Research Services Market, By Service Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biomarker Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Companion Diagnostics (CDx) Research Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Biomarker Research Services Market, By Disease Indication, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Biomarker Research Services Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Biomarker Research Services Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Qiagen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Epigenetics AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- General Electric
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Illumina, Inc.
- PerkinElmer, Inc.
- Agilent Technologies
- Becton, Dickinson and Company
- Novartis AG
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
